ESCCardiology2019
ESC Guidelines on Chronic Coronary Syndromes 2019
Published by European Society of Cardiology · 88 pages · Class I
Class I, first-lineCCTA
Class IAspirin
Class IStatin
Summary
Free previewReplaces stable angina terminology with chronic coronary syndromes. Introduces functional testing and coronary CT angiography as first-line imaging. Anti-anginal therapy algorithm updated with ranolazine and ivabradine as add-on options. Aspirin 75–100 mg and statin remain Class I for all CCS.
Chronic Coronary SyndromesStable anginaCCTARevascularisationAnti-anginal
Key Recommendations
Evidence Grading & Drug Doses
What's New vs Previous Version
Implementation & Clinical Pearls
Full guideline access requires an account
Create a free Prognia account to read the complete guideline — including all recommendations, evidence tables, drug dosing, and clinical pearls.
Full guideline text with all recommendations
Evidence grades (Class I/II/III, Level A/B/C)
AI-generated summary and clinical pearls
Auto-logged as CPD/CME activity
Free plan includes 10 guideline reads per day · No credit card required